相关实验视频

Updated: Jul 2, 2025

Protocol for the Differentiation of Human Induced Pluripotent Stem Cells into Mixed Cultures of Neurons and Glia for Neurotoxicity Testing

Protocol for the Differentiation of Human Induced Pluripotent Stem Cells into Mixed Cultures of Neurons and Glia for Neurotoxicity Testing

Published on: June 9, 2017

псилоцибин对高葡萄糖/脂质诱导的INS-1细胞活力和脱差变化的影响

Esmaeel Ghasemi Gojani¹, Bo Wang¹, Dong-Ping Li¹

¹Department of Biological Sciences, University of Lethbridge, Lethbridge, AB T1K 3M4, Canada.

|February 24, 2024

概括

魔法中的一种化合物psilocybin可能会保护胰岛素生成β细胞免受高葡萄糖和脂质损伤. 这项研究表明,psilocybin可能是治疗II型糖尿病的新疗法.

科学领域:

内分泌学和新陈代谢学
神经科学是一个神经科学.
药理学药理学是指药理学的学科.

背景情况:

血清素在β细胞的生长和功能中起着至关重要的作用.
赛洛西宾是一种血清素激动剂,与5-HT2A和5-HT2B受体相互作用.
二型糖尿病的特点是贝塔细胞功能障碍和损失.

研究的目的:

在体外 (in vitro) 调查西对β细胞活力,分化和功能的影响.
探索psilocybin在缓解高葡萄糖高脂质诱导β细胞损伤方面的潜在作用.

主要方法:

使用了INS-1 832/13鼠类胰岛素瘤细胞系.
在暴露于高葡萄糖高脂质条件之前,用psilocybin预处理的细胞.
分析了总转录和细胞蛋白的分子变化.

主要成果:

赛洛西宾预治疗减轻了因高葡萄糖-高脂质条件引起的β细胞损失.
松素调节的亡生物标记物和TXNIP,STAT-1和STAT-3的酸化.
松素影响了β细胞脱分标记物的表达 (Pou5f1,Nanog).

结论:

西显示出对β细胞损伤的保护作用.
西可能会减弱β细胞的脱差.
需要对二型糖尿病干预措施的psilocybin进行进一步的研究.

关键词:

糖尿病糖尿病患者糖尿病患者这种药物是psilocybin.在β细胞脱差分化的过程中,β细胞脱差分.失去了β细胞的损失.

更多相关视频

Author Spotlight: Advancements and Challenges in β-Cells Differentiation from Pluripotent Stem Cells

Author Spotlight: Advancements and Challenges in β-Cells Differentiation from Pluripotent Stem Cells

Published on: February 2, 2024

Isolated Pancreatic Islet Treatment and Apoptosis Measurement

Isolated Pancreatic Islet Treatment and Apoptosis Measurement

Published on: May 2, 2025

相关概念视频

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.